These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 929540)
21. Oral contraception and breast pathology. Ragni N; Boccardo E; Viglino S; Larosa E Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288 [TBL] [Abstract][Full Text] [Related]
22. [Contraceptives and breast cancer (author's transl)]. Mauvais-Jarvis P; Kuttenn F Contracept Fertil Sex (Paris); 1976 Sep; 4(5):343-8. PubMed ID: 992191 [No Abstract] [Full Text] [Related]
23. [Oral contraception and multiple sclerosis]. Ghezzi A; Caputo D; Manara F; Mainini E Arch Sci Med (Torino); 1979; 136(1):67-73. PubMed ID: 380517 [TBL] [Abstract][Full Text] [Related]
24. [Considerations on the long-term effect of an iatrogenic hazard]. Csaba G Orv Hetil; 1977 Aug; 118(33):1947-51. PubMed ID: 887265 [No Abstract] [Full Text] [Related]
27. Cancer risks from estrogen intake. Greenwald P; Nasca PC; Caputo TA; Janerich DT N Y State J Med; 1977 Jun; 77(7):1069-74. PubMed ID: 267252 [No Abstract] [Full Text] [Related]
28. Clinical pharmacology and common minor side effects of oral contraceptives. DeLia JE; Emery MG Clin Obstet Gynecol; 1981 Sep; 24(3):879-92. PubMed ID: 7026109 [No Abstract] [Full Text] [Related]
29. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents]. Gambini G; Farina G; Arbosti G Med Lav; 1976; 67(2):152-7. PubMed ID: 1021708 [No Abstract] [Full Text] [Related]
30. [Hormonal contraception and cancer risk]. Ebeling K; Göretzlehner G Z Arztl Fortbild (Jena); 1985; 79(9):365-7. PubMed ID: 4024671 [No Abstract] [Full Text] [Related]
32. [Dependence of morphologic changes in portio, cervix and endometrium on dosage or potency of synthetic gestagens]. Dallenbach-Hellweg G; Fenzel J Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):238-43. PubMed ID: 3159618 [TBL] [Abstract][Full Text] [Related]
33. Hepatic adenomas and focal nodular hyperplasia of the liver in young women on oral contraceptives: case reports. Jhingran SG; Mukhopadhyay AK; Ajmani SK; Johnson PC J Nucl Med; 1977 Mar; 18(3):263-6. PubMed ID: 839274 [TBL] [Abstract][Full Text] [Related]
35. Tumorigenic aspects. Kirk ME Int J Gynaecol Obstet; 1978-1979; 16(6):473-8. PubMed ID: 39811 [TBL] [Abstract][Full Text] [Related]
36. Oral contraceptives and endometrial and cervical cancer. Moghissi KS J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901 [No Abstract] [Full Text] [Related]
37. Synthetic gestagens and endocervical adenocarcinoma. Dallenbach-Hellweg G Int J Gynecol Pathol; 1984; 3(2):241. PubMed ID: 6490316 [No Abstract] [Full Text] [Related]
38. [The effect of oral hormonal contraception on the incidence of carcinoma and dysplasia of the cervix]. Kovacic J; Andolsek L; Kozuh M; Litt B Jugosl Ginekol Opstet; 1981; 21(1-2):11-6. PubMed ID: 7052391 [No Abstract] [Full Text] [Related]